Guiding the Earliest Stages of Drug Discovery: NCI-60 Cell Screen
Guiding the Earliest Stages of Drug Discovery: NCI-60 Cell Screen
The development of the NCI-60 Cell Screen was challenging, but now it is a critical research tool that guides the earliest stages of drug discovery. Michael Boyd, M.D., Ph.D., former associate director of DTP, describes the early challenges of the cell screen and its successes.